Kayla Z. X. Southworth
Partner
New York
Kayla Southworth is a partner in the New York office and a member of the M&A and Private Equity Group and Life Sciences & HealthTech Group.
Kayla advises public and private life sciences, technology, and energy companies, and private equity funds and their portfolio companies, on domestic and cross-border mergers and acquisitions, minority and majority investments, joint ventures, licenses, collaborations, royalty and revenue-sharing financings, and other complex transactions. She also advises clients on New York and Delaware corporate, partnership, limited liability company, and non-profit law, including corporate governance and fiduciary duty matters.
Prior to joining Orrick, she was an Antitrust Associate at Davis Polk and a Litigation Associate at Sullivan & Cromwell.
-
Kayla's recent transactions include representing:
- DURECT Corporation, a late-stage biopharmaceutical company, on its acquisition by Bausch Health Companies Inc., a global pharmaceutical company
- Carlyle and SK Capital Partners on their acquisition of bluebird bio, a pioneer in gene therapies for severe genetic diseases
- Virios Therapeutics on its business combination with Wex Pharmaceuticals to form Dogwood Therapeutics
- Onconova Therapeutics on its business combination with Trawsfynydd Therapeutics
- Twist Bioscience Corporation, a core mid-cap growth and value equity company in the life sciences segment of the health care sector, on the spin out of its DNA data storage technology application as an independent company, named Atlas Data Storage
- Sosei Group Corporation, a fully integrated biopharmaceutical company, on its CHF 400 million acquisition of Idorsia’s Japan and APAC (ex-China) pharmaceuticals business
- Ferring Pharmaceuticals on several M&A and collaboration transactions
- Workday on its acquisition of Pipedream
- D2L, a Canada based company specializing in learning innovation, on its acquisition of H5P Group
- RapidMiner, a data analytics and machine learning software company, on its acquisition by Altair Engineering, a global leader in computational science and artificial intelligence solutions, for $100 million
- Catalyst Biosciences, Inc. on the sale of its complement asset portfolio for $60 million in cash
- Warburg Pincus and its portfolio company Qualifacts on its merger with Credible Behavioral Health and the add-on acquisition of InSync Healthcare Solutions
- Apex Clean Energy on the sale of a majority stake to funds managed by Ares Management Corporation
- Aria Energy on its business combination with Archaea Energy and SPAC Rice Acquisition Corporation
- GCX Mounting Solutions, a family owned, global leader in the design and manufacturing of healthcare-focused, mission-critical equipment mounting and mobility solutions, on its acquisition by private equity funds managed by Audax Private Equity
- Aptean on its acquisition of Open Systems Adaptable Solutions
- K12 on its $165 million acquisition of Galvanize
- Shopify on its $450 million acquisition of 6 River Systems
